Cargando…
Preclinical Safety Assessment of Bacillus subtilis BS50 for Probiotic and Food Applications
Despite the commercial rise of probiotics containing Bacillaceae spp., it remains important to assess the safety of each strain before clinical testing. Herein, we performed preclinical analyses to address the safety of Bacillus subtilis BS50. Using in silico analyses, we screened the 4.15 Mbp BS50...
Autores principales: | Brutscher, Laura M., Borgmeier, Claudia, Garvey, Sean M., Spears, Jessica L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144164/ https://www.ncbi.nlm.nih.gov/pubmed/35630480 http://dx.doi.org/10.3390/microorganisms10051038 |
Ejemplares similares
-
The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial
por: Garvey, Sean M., et al.
Publicado: (2022) -
The Probiotic Bacillus subtilis MB40 Improves Immunity in a Porcine Model of Listeriosis
por: Garvey, Sean M., et al.
Publicado: (2023) -
Safety Assessment of Bacillus subtilis MB40 for Use in Foods and Dietary Supplements
por: Spears, Jessica L., et al.
Publicado: (2021) -
Genome Sequencing and Annotation of Bacillus subtilis UBBS-14 to Ensure Probiotic Safety
por: Sulthana, Ayesha, et al.
Publicado: (2019) -
Bacillus licheniformis and Bacillus subtilis, Probiotics That Induce the Formation of Macrophage Extracellular Traps
por: Romo-Barrera, Carol M., et al.
Publicado: (2021)